Search
Search Menu

Research rigor in preclinical studies on biological effects of whole-body exposure to electromagnetic fields (2G/3G cell phone technology)

Various modern technologies are known to bear risks to the human health. In many cases, the society learns about these risks only once negative consequences have become obvious, for example in the cases of asbestos, DDT and, most recently, the broad-spectrum systemic herbicide Glyphosate. In the …

Read more

New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology

To improve the robustness and transparency of scientific reporting, the American Society for Pharmacology and Experimental Therapeutics (ASPET), with input from PAASP’s Martin Michel, T.J. Murphy and Harvey Motulsky, has updated the Instructions to Authors (ItA) for ASPET’s primary research journals: Drug Metabolism and Disposition, Journal of Pharmacology and Experimental …

Read more

Presentation of the newly developed Guidelines On Target Validation for Innovative Therapeutics (GOT-IT)

Representing the GOT-IT Team, Christoph Emmerich presented the GOT-IT Guidelines at the “BMBF Vernetzungstreffen zur Nationalen Wirkstoffinitiative” on the 8th of October 2019, which was attended by academic PIs, industry representatives, officials from the Federal Ministry of Education and Research and members of the German Parliament.Furthermore, PAASP …

Read more

PDN Training Workshop

Feb 27 – Mar 1, 2019 (Athens, Greece)“How to Make Preclinical Research Robust”2nd Preclinical Data Network Training Workshop for Young ScientistsCoordinators (Europe): Anton Bespalov (PAASP), Thomas Steckler (Janssen)Coordinators (North America): Magali Haas, Patricia Kabitzke, Chantelle Ferland-Beckham (Cohen Veterans Bioscience)Local organizers: Christina Dalla, Nikolaos Kokras (National and Kapodistrian …

Read more

Scroll Up